A share price of ProKidney Corp [PROK] is currently trading at $2.35, up 6.82%. An important factor to consider is whether the stock is rising or falling in short-term value. The PROK shares have gain 8.29% over the last week, with a monthly amount glided 4.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ProKidney Corp [NASDAQ: PROK] stock has seen the most recent analyst activity on December 16, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $12. Previously, BofA Securities downgraded its rating to Underperform on June 30, 2025, and kept the price target unchanged to $1. On September 30, 2024, JP Morgan initiated with a Neutral rating. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $6 on September 10, 2024. BofA Securities downgraded its rating to Neutral for this stock on January 02, 2024. In a note dated July 25, 2023, BTIG Research initiated a Buy rating and provided a target price of $16 on this stock.
ProKidney Corp experienced fluctuations in its stock price throughout the past year between $0.46 and $7.13. Currently, Wall Street analysts expect the stock to reach $4.67 within the next 12 months. ProKidney Corp [NASDAQ: PROK] shares were valued at $2.35 at the most recent close of the market. An investor can expect a potential return of 98.72% based on the average PROK price forecast.
Analyzing the PROK fundamentals
Gross Profit Margin for this corporation currently stands at -1.28% with Operating Profit Margin at -344.67%, Pretax Profit Margin comes in at -310.54%, and Net Profit Margin reading is -137.52%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is 0.11 and Total Capital is -0.53. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.24 points at the first support level, and at 2.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.43, and for the 2nd resistance point, it is at 2.50.
Ratios To Look Out For
To put it in perspective, the Current Ratio for ProKidney Corp [NASDAQ:PROK] is 10.32. On the other hand, the Quick Ratio is 10.32, and the Cash Ratio is 3.01. Considering the valuation of this stock, the price to sales ratio is 955.36.
Transactions by insiders
Recent insider trading involved Pereira Brian JG, Director, that happened on Nov 13 ’25 when 0.5 million shares were sold. Director, Pereira Brian JG completed a deal on Nov 12 ’25 to sell 0.26 million shares. Meanwhile, Director Brian Pereira bought 0.68 million shares on Nov 12 ’25.
